These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 7304632)

  • 21. Comparison of kaolin-pectin and activated charcoal for inhibition of aspirin absorption.
    Juhl RP
    Am J Hosp Pharm; 1979 Aug; 36(8):1097-8. PubMed ID: 484570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical pharmacokinetics of aspirin.
    Levy G
    Pediatrics; 1978 Nov; 62(5 Pt 2 Suppl):867-72. PubMed ID: 724339
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pharmacokinetics and relative bioavailability of KC-404 sustained release tablets in healthy volunteers].
    Li T; Pang Y; Wang Z; Jia Y; Cheng Q; Sun J
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Jul; 34(3):541-3. PubMed ID: 12910715
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of meals and dosage-form modification on theophylline bioavailability from a 24-hour sustained-release delivery system.
    González MA; Straughan AB
    Clin Ther; 1994; 16(5):804-14. PubMed ID: 7859239
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effects of enteric coating of aspirin tablets on occult gastrointestinal blood loss.
    Howe GB; Champion GD; Corrigan AB; Hewson J; Haski A; Day RO; Paull PD; Graham GG
    Aust N Z J Med; 1977 Dec; 7(6):600-4. PubMed ID: 350214
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparative study of the bioavailability and the pharmacodynamic effect of five allopurinol preparations (author's transl)].
    Jaeger H; Russmann D; Rasper J; Blome J
    Arzneimittelforschung; 1982; 32(4):438-43. PubMed ID: 6896646
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma salicylate levels in rheumatoid arthritis produced by four different salicylate preparations.
    Armstrong BK; Ukich AW; Goatcher PM
    Med J Aust; 1970 Jul; 2(4):181-3. PubMed ID: 4917130
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparison of the pharmacokinetic profiles of soluble aspirin and solid paracetamol tablets in fed and fasted volunteers.
    Stillings M; Havlik I; Chetty M; Clinton C; Schall R; Moodley I; Muir N; Little S
    Curr Med Res Opin; 2000; 16(2):115-24. PubMed ID: 10893655
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bioequivalence of a new sustained-release formulation of sodium valproate, valproate modified-release granules, compared with existing sustained-release formulations after once- or twice-daily administration.
    Dulac O; Alvarez JC
    Pharmacotherapy; 2005 Jan; 25(1):35-41. PubMed ID: 15767218
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Steady-state salicylate plasma and urinary metabolite concentrations from plain, buffered, or enteric-coated aspirin.
    Allen JH; Thakker KM; Small RE; Wood JH; Willis HE
    Clin Pharm; 1983; 2(1):64-6. PubMed ID: 6883933
    [No Abstract]   [Full Text] [Related]  

  • 31. Pharmacokinetics of sustained-release tablets of metoprolol in Chinese.
    Diao Y; Li L
    Zhongguo Yao Li Xue Bao; 1993 May; 14(3):232-4. PubMed ID: 8237398
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of pharmacokinetic and pharmacodynamic profiles of aspirin following oral gavage and diet dosing in rats.
    Kapetanovic IM; Bauer KS; Tessier DM; Lindeblad MO; Zakharov AD; Lubet R; Lyubimov A
    Chem Biol Interact; 2009 May; 179(2-3):233-9. PubMed ID: 18992230
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of controlled-release on the pharmacokinetics and absorption characteristics of a compound undergoing intestinal efflux in humans.
    Tubic M; Wagner D; Spahn-Langguth H; Weiler C; Wanitschke R; Böcher WO; Langguth P
    Eur J Pharm Sci; 2006 Nov; 29(3-4):231-9. PubMed ID: 16713700
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative bioavailability study of a generic sustained release diclofenac sodium tablet.
    Magosso E; Yuen KH; Choy WP; Ling SS; Ng BH; Ur-Rahman N; Wong JW
    Med J Malaysia; 2004 Aug; 59(3):352-6. PubMed ID: 15727381
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bioavailability of sustained-release aspirin preparations.
    Lobeck F; Spigiel RW
    Clin Pharm; 1986 Mar; 5(3):236-8. PubMed ID: 3956130
    [No Abstract]   [Full Text] [Related]  

  • 36. Pharmacokinetics of a controlled release preparation of naproxen.
    Strocchi E; Ambrosioni E; Palazzini E; Galli G
    Int J Clin Pharmacol Ther Toxicol; 1991 Jul; 29(7):253-6. PubMed ID: 1889910
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A phase I, randomized, open-label, crossover study of the single-dose pharmacokinetic properties of guanfacine extended-release 1-, 2-, and 4-mg tablets in healthy adults.
    Swearingen D; Pennick M; Shojaei A; Lyne A; Fiske K
    Clin Ther; 2007 Apr; 29(4):617-25. PubMed ID: 17617285
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sustained release aspirin.
    Pomare EW; Treadwell BL
    N Z Med J; 1971 Mar; 73(466):139-43. PubMed ID: 4930820
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparative bioavailability of a metoprolol controlled release formulation and a bisoprolol normal release tablet after single oral dose administration in healthy volunteers.
    Deroubaix X; Lins RL; Lens S; Demblon C; Jeanbaptiste B; Poelaert D; Stockis A
    Int J Clin Pharmacol Ther; 1996 Feb; 34(2):61-70. PubMed ID: 8929748
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Some observations on blood level data following oral administration of aspirin as tablets and capsules.
    Garnham J; Hicks DC; Raymond K; Shotton E; Turner P
    Br J Pharmacol; 1973 Jun; 48(2):336P. PubMed ID: 4582150
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.